Exploration of the structural requirements of Aurora Kinase B inhibitors by a combined QSAR, modelling and molecular simulation approach. (2021)

First Author: Ashraf S
Attributed to:  Commercialisation of VR for biomolecular design funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41598-021-97368-3

PubMed Identifier: 34548506

Publication URI: http://europepmc.org/abstract/MED/34548506

Type: Journal Article/Review

Volume: 11

Parent Publication: Scientific reports

Issue: 1

ISSN: 2045-2322